Myrexis Competitors and Similar CompaniesClear all
Myrexis's competitors and similar companies include Takeda, Genocea Biosciences, Merrimack Pharmaceuticals and Oncopeptides.
 Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. |  Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. | |||
Founding Date | Founding Date 1999 | Founding Date 1781 | Founding Date 2006 | Founding Date 2000 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations New York, US HQ | Locations Cambridge, US HQ | Locations Cambridge, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | |
Employees | Employees N/A | Employees 47,4554% decrease | Employees 593% decrease | Employees 2763% decrease | Employees 80 |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 43.7 b | Valuation ($) 5.7 k | Valuation ($) 223.7 m | Valuation ($) 42.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $1.6m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) kr71.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods kr2.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit kr72m (FY, 2025) |
Net income | Net income N/A | Net income ¥108.1b (FY, 2025) | Net income ($33.2m) (FY, 2021) | Net income ($1.2m) (FY, 2023) | Net income (kr249.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised $ 209.5m | Total funding raised $ 79.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyGenocea Biosciences
HQ
Cambridge, US
Employees
59↓ 3% decrease
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
View companyMerrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company